
"Nurses are essential
collaborators in translational cancer research, bringing new and
effective treatments from the research laboratory to the patient,"
stated SU2C President and CEO, Sung Poblete, RN, PhD who holds a PhD in Nursing from Rutgers University.
"SU2C is at the forefront of immunoncology research and we recognize
that an essential part of bringing these cutting-edge therapies to
patients is the effective dissemination of information about the
treatments. Nurses play an integral role in patient management and these
modules will provide a new toolkit for patient care."
No comments:
Post a Comment